Voyager Therapeutics, Inc. revenue breakdown overview

Voyager Therapeutics, Inc. revenue for the last year amounted to 250.01 M USD, the most of which — 250.01 M USD — came from its highest performing source at the moment, Gene Therapies, the year earlier bringing 40.91 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Voyager Therapeutics, Inc. 250.01 M USD, and the year before that — 40.91 M USD.